e-learning
resources
Vienna 2012
Tuesday, 04.09.2012
Cellular signalling mechanisms in the airways
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Formoterol restores oxidative stress-induced corticosteroid insensitivity via activation of protein phosphatase PP2A
Y. Kobayashi, N. Mercado, A. Miller-Larsson, P.J. Barnes (London, United Kingdom; Molndal, Sweden)
Source:
Annual Congress 2012 - Cellular signalling mechanisms in the airways
Session:
Cellular signalling mechanisms in the airways
Session type:
Poster Discussion
Number:
3417
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Kobayashi, N. Mercado, A. Miller-Larsson, P.J. Barnes (London, United Kingdom; Molndal, Sweden). Formoterol restores oxidative stress-induced corticosteroid insensitivity via activation of protein phosphatase PP2A. Eur Respir J 2012; 40: Suppl. 56, 3417
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Protein phosphatase PP2A activation by formoterol reverses corticosteroid insensitivity
Source: Annual Congress 2009 - Airway cell biology
Year: 2009
Activated protein phosphatase PP2A by formoterol enhances nuclear translocation of glucocorticoid receptor induced by budesonide
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
A novel macrolide/fluoroketolide, solithromycin (CEM-101), reverses corticosteroid insensitivity via activation of protein phosphatase PP2A
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011
Pharmacological induction of HDAC activity restores steroid function in macrophages subjected to oxidative stress
Source: Eur Respir J 2005; 26: Suppl. 49, 214s
Year: 2005
Corticosteroid insensitivity and enhanced mitogen-activated protein kinase activity in airway smooth muscle cells of severe asthma
Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology
Year: 2011
Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma
Source: Eur Respir J 2010; 35: 750-756
Year: 2010
Oxidative stress-mediated decrease in histone deacetylase activity is attenuated by N-acetyl-L-cysteine but not by Iκ-B kinase inhibition in alveolar epithelial cells
Source: Eur Respir J 2004; 24: Suppl. 48, 29s
Year: 2004
Impaired protein tyrosine phosphatase PTPRR reduces response to corticosteroid in mononuclear cells
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013
MAP kinase phosphatase 1 mediates glucocorticoid inhibition of CD38 expression in human airway smooth muscle
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Oxidative stress-induced corticosteroid insensitivity is reversed by formoterol via inhibition of PI3K signalling in peripheral blood mononuclear cells from patients with COPD and severe asthma
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
Erythromycin restores HDAC2 levels diminished under oxidative and inflammatory stress
in vitro
and
in vivo
Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Year: 2008
Effect of PDE4 inhibitors on MAPK activation and IL-8 production on A549 cells following the induction of oxidative stress
Source: Eur Respir J 2005; 26: Suppl. 49, 99s
Year: 2005
Oxidative stress induces arachidonic acid release from human lung cells through the EGFR pathway leading to cPLA2 phosphorylation
Source: Annual Congress 2003 - Intracellular signalling and regulation of cytokine production
Year: 2003
DJ-1 and its anti-oxidative stress response regulates the expression of sirtuin-1 in COPD epithelial cells
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
MAPK inhibition modulates Hsp27 phosphorylation and glutathione in lung epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 192s
Year: 2006
Inhibition of ER stress suppresses IL-13 induced airway epithelial remodeling
Source: International Congress 2019 – COPD, asthma and rhinitis: from cellular mechanisms to patients’ clinical responses
Year: 2019
Inhibition of c-kit tyrosine kinase by sunitinib alleviates airway remodeling in a mouse model of chronic asthma
Source: Annual Congress 2009 - Preclinical models in drug development
Year: 2009
iNOS inhibition modulates lung tissue inflammation via oxidative stress pathway activation
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008
SH2 domain-containing Phosphatase-(SHP)-2 blunts fibrotic responses through regulation of fibroblast mitochondrial metabolism and autophagy
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
The RNA binding protein HuR regulates the senescence-associated secretory phenotype under conditions of oxidative stress
Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept